Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Down 96.2% in November

Oxford Biomedica plc (OTCMKTS:OXBDF) was the target of a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 100 shares, a drop of 96.2% from the October 31st total of 2,600 shares. Based on an average trading volume of 2,800 shares, the days-to-cover ratio is currently 0.0 days.

Oxford Biomedica Price Performance

OTCMKTS:OXBDF remained flat at $5.20 on Thursday. Oxford Biomedica has a 52-week low of $2.09 and a 52-week high of $5.68. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48. The company has a fifty day moving average of $5.17 and a two-hundred day moving average of $4.59.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.